265 related articles for article (PubMed ID: 34999396)
21. Activating Adenosine Monophosphate-Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice.
Lin Q; Huang Z; Cai G; Fan X; Yan X; Liu Z; Zhao Z; Li J; Li J; Shi H; Kong M; Zheng MH; Conklin DJ; Epstein PN; Wintergerst KA; Mohammadi M; Cai L; Li X; Li Y; Tan Y
Hepatology; 2021 Jun; 73(6):2206-2222. PubMed ID: 32965675
[TBL] [Abstract][Full Text] [Related]
22. Astaxanthin Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Intestinal Flora and Targeting the AMPK/Nrf2 Signal Axis.
Li Y; Liu J; Ye B; Cui Y; Geng R; Liu S; Zhang Y; Guo W; Fu S
J Agric Food Chem; 2022 Aug; 70(34):10620-10634. PubMed ID: 35973099
[TBL] [Abstract][Full Text] [Related]
23. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596
[TBL] [Abstract][Full Text] [Related]
24. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
[TBL] [Abstract][Full Text] [Related]
25. Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice.
Tao W; Sun W; Liu L; Wang G; Xiao Z; Pei X; Wang M
Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31744059
[TBL] [Abstract][Full Text] [Related]
26. Plant sterol ester of α-linolenic acid ameliorates high-fat diet-induced nonalcoholic fatty liver disease in mice: association with regulating mitochondrial dysfunction and oxidative stress via activating AMPK signaling.
Han H; Li X; Guo Y; Zheng M; Xue T; Wang L
Food Funct; 2021 Mar; 12(5):2171-2188. PubMed ID: 33566044
[TBL] [Abstract][Full Text] [Related]
27. Electromagnetic fields ameliorate hepatic lipid accumulation and oxidative stress: potential role of CaMKKβ/AMPK/SREBP-1c and Nrf2 pathways.
Zhai M; Zhang C; Cui J; Liu J; Li Y; Xie K; Luo E; Tang C
Biomed Eng Online; 2023 May; 22(1):51. PubMed ID: 37217972
[TBL] [Abstract][Full Text] [Related]
28. PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway.
Huang B; Xiong X; Zhang L; Liu X; Wang Y; Gong X; Sang Q; Lu Y; Qu H; Zheng H; Zheng Y
J Mol Cell Biol; 2021 Oct; 13(7):527-539. PubMed ID: 34048566
[TBL] [Abstract][Full Text] [Related]
29. (-)-Hydroxycitric Acid Alleviates Oleic Acid-Induced Steatosis, Oxidative Stress, and Inflammation in Primary Chicken Hepatocytes by Regulating AMP-Activated Protein Kinase-Mediated Reactive Oxygen Species Levels.
Li L; Chu X; Yao Y; Cao J; Li Q; Ma H
J Agric Food Chem; 2020 Oct; 68(40):11229-11241. PubMed ID: 32940033
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
[TBL] [Abstract][Full Text] [Related]
31. Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways.
Shen B; Feng H; Cheng J; Li Z; Jin M; Zhao L; Wang Q; Qin H; Liu G
J Cell Mol Med; 2020 May; 24(9):5097-5108. PubMed ID: 32293113
[TBL] [Abstract][Full Text] [Related]
32. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
[TBL] [Abstract][Full Text] [Related]
33. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
[TBL] [Abstract][Full Text] [Related]
34. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway.
Xu N; Luo H; Li M; Wu J; Wu X; Chen L; Gan Y; Guan F; Li M; Su Z; Chen J; Liu Y
Biomed Pharmacother; 2021 Feb; 134():111104. PubMed ID: 33341045
[TBL] [Abstract][Full Text] [Related]
35. Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway.
Chang TC; Chiou WC; Lai WH; Huang HC; Huang YL; Liu HK; Liang YC; Huang C
Pharmacol Res; 2021 Jan; 163():105298. PubMed ID: 33220422
[TBL] [Abstract][Full Text] [Related]
36. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
37. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
[TBL] [Abstract][Full Text] [Related]
38. Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation.
Feng X; Yu W; Li X; Zhou F; Zhang W; Shen Q; Li J; Zhang C; Shen P
Biochem Pharmacol; 2017 Jul; 136():136-149. PubMed ID: 28414138
[TBL] [Abstract][Full Text] [Related]
39. Monkfish Peptides Mitigate High Fat Diet-Induced Hepatic Steatosis in Mice.
Ye J; Tian X; Wang Q; Zheng J; Yang Y; Xu B; Zhang S; Yuan F; Yang Z
Mar Drugs; 2022 May; 20(5):. PubMed ID: 35621963
[TBL] [Abstract][Full Text] [Related]
40. Exercise Intervention Mitigates Pathological Liver Changes in NAFLD Zebrafish by Activating SIRT1/AMPK/NRF2 Signaling.
Zou Y; Chen Z; Sun C; Yang D; Zhou Z; Peng X; Zheng L; Tang C
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]